PDE4D and fragile X syndrome: Perhaps the most exciting, targeted treatment for FXS is the Tetra drug called BPN14770 (Zitolamast), which is a phosphodiesterase 4D (PDE4D) inhibitor that inhibits the breakdown of cyclic adenosine monophosphate (cAMP), which is too low in FXS.